<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00636584</url>
  </required_header>
  <id_info>
    <org_study_id>2008-0048</org_study_id>
    <nct_id>NCT00636584</nct_id>
  </id_info>
  <brief_title>Clinical Study Investigating the Effect of Sodium Nitroprusside Infusion on Thyroidal Function</brief_title>
  <official_title>Does Sodium Nitroprusside Infusion Affect Thyroidal Function in Patients Undergoing Coronary Artery Bypass Grafting, a Prospective Randomized Clinical Trial.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Kavaklıdere Umut Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Ankara University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Kavaklıdere Umut Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Whether use of SNP during cardiac surgery has any effect on thyroid function has not yet been
      investigated in humans. The aim of this study was to investigate the effects of SNP
      administration during the rewarming period of cardiac operations on circulating levels of
      thyroid hormones.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>February 2008</start_date>
  <completion_date type="Anticipated">March 2008</completion_date>
  <primary_completion_date type="Actual">February 2008</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Screening</primary_purpose>
    <masking>Single (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>free T3</measure>
    <time_frame>on admission, prior to operation, at the beginning of CPB, following CPB, at first, third and fifth postoperative days</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>total T3</measure>
    <time_frame>on admission, prior to operation, at the beginning of CPB, following CPB, on the first, third and fifth postoperative days</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">106</enrollment>
  <condition>Nitroprusside</condition>
  <condition>Thyroid Hormones</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>arm1: sodium nitroprusside group</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>arm2: control group,saline infused instead of sodium nitroprusside</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>sodium nitroprusside</intervention_name>
    <description>sodium nitroprusside infusion at 1 microgram/kg/min dose during rewarming period of cardiac operations</description>
    <arm_group_label>1</arm_group_label>
    <other_name>nipruss</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>placebo</intervention_name>
    <description>placebo</description>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Patients without history of:

          -  thyroidal disease

          -  hypertension

          -  pulmonary disease

          -  peripheral vascular disease

          -  stroke

          -  recent myocardial infarction within the week prior to operation

          -  unstable angina pectoris

          -  liver or kidney dysfunction

          -  morbid obesity

          -  cachexia

          -  sulfonylurea intake

        Exclusion Criteria:

          -  Patients who needed positive inotropic pharmacologic support during or after the
             operation

          -  Patients who developed atrial fibrillation in the post operative period requiring
             amiodarone therapy

          -  In addition, patients receiving any medication known to interfere with any step of
             thyroid hormone metabolism such as

               -  amiodarone

               -  propranolol

               -  furosemide

               -  non-steroidal anti-inflammatory agents

               -  steroids

               -  estrogens

               -  antacids

               -  diphenylhydantoin

               -  spironolactone
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>alp aslan, md</last_name>
    <role>Study Director</role>
    <affiliation>kavaklıdere Umut Hastanesi, Turkey</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>alp aslan, md</last_name>
    <phone>0905425179917</phone>
    <email>alpslan@yahoo.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Kavaklıdere Umut Hastanesi</name>
      <address>
        <city>Ankara</city>
        <zip>06660</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alp Aslan, MD</last_name>
      <phone>0905425179917</phone>
      <email>alpslan@yahoo.com</email>
    </contact>
    <contact_backup>
      <last_name>Selen Osmanağaoğlu, MD</last_name>
      <phone>0905324675969</phone>
      <email>sosmanaga@gmail.com</email>
    </contact_backup>
    <investigator>
      <last_name>alp aslan, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <link>
    <url>http://www.cityhospital.com.tr/</url>
    <description>home page of kavaklidere umut hospital</description>
  </link>
  <verification_date>March 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 7, 2008</study_first_submitted>
  <study_first_submitted_qc>March 7, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 14, 2008</study_first_posted>
  <last_update_submitted>March 7, 2008</last_update_submitted>
  <last_update_submitted_qc>March 7, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 14, 2008</last_update_posted>
  <responsible_party>
    <name_title>Kavaklıdere Umut Hastanesi</name_title>
    <organization>Kavaklıdere Umut Hospital, department of cardiovascular surgery</organization>
  </responsible_party>
  <keyword>sodium nitroprusside</keyword>
  <keyword>thyroid hormones</keyword>
  <keyword>thoracic surgery</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Nitroprusside</mesh_term>
  </intervention_browse>
  <pending_results>
    <submitted>December 15, 2008</submitted>
    <submission_canceled>Unknown</submission_canceled>
    <submitted>December 17, 2008</submitted>
    <returned>January 21, 2009</returned>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

